{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:45:35Z","timestamp":1792118735696,"version":"4.4.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.04.080","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T14:49:01Z","timestamp":1494514141000},"page":"2326-2334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors"],"prefix":"10.1016","volume":"106","author":[{"given":"Mie","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2017.04.080_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1471-4159.1998.70051781.x","article-title":"CNS drug design based on principles of blood-brain barrier transport","volume":"70","author":"Pardridge","year":"1998","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cmet.2013.12.015","article-title":"Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain","volume":"19","author":"Balland","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.xphs.2017.04.080_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 ( GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.xphs.2017.04.080_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.xphs.2017.04.080_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mcn.2016.08.009","article-title":"Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers","volume":"76","author":"Hersom","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.xphs.2017.04.080_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4530(85)90079-4","article-title":"Permeability of the blood-brain barrier to neuropeptides: the case for penetration","volume":"10","author":"Banks","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.xphs.2017.04.080_bib7","first-page":"412","article-title":"Hydrogen bonding potential as a determinant of the in\u00a0vitro and in situ blood\u2013brain barrier permeability of peptides","volume":"11","author":"Chikhale","year":"1994","journal-title":"Am Assoc Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.080_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2017.04.080_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4155\/fmc.11.195","article-title":"Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins","volume":"4","author":"Li","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.xphs.2017.04.080_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(82)91227-6","article-title":"Electrical resistance of brain microvascular endothelium","volume":"241","author":"Crone","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1471-4159.1993.tb03223.x","article-title":"Peptidases, peptides, and the mammalian blood-brain barrier","volume":"60","author":"Brownlees","year":"1993","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib13","first-page":"1","article-title":"Role of transport proteins in drug absorption, distribution and excretion","volume":"32","author":"Ayrton","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2017.04.080_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.xphs.2017.04.080_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","article-title":"The translational significance of the neurovascular unit: a mini-review","volume":"292","author":"McConnell","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood-brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.xphs.2017.04.080_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.xphs.2017.04.080_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/1357-4310(96)88720-X","article-title":"Transporting therapeutics across the blood-brain barrier","volume":"2","author":"Abbott","year":"1996","journal-title":"Mol Med Today"},{"key":"10.1016\/j.xphs.2017.04.080_bib19","first-page":"672","article-title":"Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain","volume":"58","author":"Fung","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.xphs.2017.04.080_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib22","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.080_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109509","article-title":"Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery","volume":"64","author":"Neuwelt","year":"1979","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.xphs.2017.04.080_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pbiomolbio.2006.07.019","article-title":"Ultrasound, microbubbles and the blood-brain barrier","volume":"93","author":"Meairs","year":"2007","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.xphs.2017.04.080_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.xphs.2017.04.080_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.xphs.2017.04.080_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11064-016-2030-x","article-title":"Solute carriers in the blood\u2013brain barrier: safety in abundance","volume":"43","author":"Na\u0142\u0119cz","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib28","first-page":"1","article-title":"Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery","volume":"8222","author":"Pardridge","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.xphs.2017.04.080_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/j.xphs.2017.04.080_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","article-title":"Human blood-brain barrier insulin receptor","volume":"44","author":"Pardridge","year":"1985","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(00)02794-3","article-title":"Improved bioavailability to the brain of glycosylated Met-enkephalin analogs","volume":"881","author":"Egleton","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib32","first-page":"4771","article-title":"Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Med Sci Nat"},{"key":"10.1016\/j.xphs.2017.04.080_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2006.07.005","article-title":"Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion","volume":"1111","author":"Zhang","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse","volume":"292","author":"Lee","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xphs.2017.04.080_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1479-7364-3-2-195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Hum Genomics"},{"key":"10.1016\/j.xphs.2017.04.080_bib37","first-page":"1","article-title":"Nanobodies as modulators of inflammation: potential applications for acute brain injury","volume":"344","author":"Rissiek","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.xphs.2017.04.080_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"Freskg\u00e5rd","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xphs.2017.04.080_bib39","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.1074\/jbc.M111.330902","article-title":"Highly aggregated antibody therapeutics can enhance the in\u00a0vitro innate and late-stage T-cell immune responses","volume":"287","author":"Joubert","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib40","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1128\/JVI.74.23.11359-11366.2000","article-title":"Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium","volume":"74","author":"Xia","year":"2000","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.xphs.2017.04.080_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/bc400055h","article-title":"B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide","volume":"24","author":"Liu","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Staquicini","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.xphs.2017.04.080_bib43","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1016\/j.biomaterials.2013.08.039","article-title":"LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.04.080_bib44","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1073\/pnas.88.12.5242","article-title":"Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions","volume":"88","author":"Fasano","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.080_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2015.04.025","article-title":"Toxins and derivatives in molecular pharmaceutics: drug delivery and targeted therapy","volume":"90","author":"Zhan","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.04.080_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.gt.3302525","article-title":"Delivery into cells: lessons learned from plant and bacterial toxins","volume":"12","author":"Sandvig","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nbt1201-1173","article-title":"A\u00a0peptide carrier for the delivery of biologically active proteins into mammalian cells","volume":"19","author":"Morris","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xphs.2017.04.080_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/bc5005763","article-title":"Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation","volume":"26","author":"Kristensen","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib49","doi-asserted-by":"crossref","first-page":"e1178369","DOI":"10.1080\/21688370.2016.1178369","article-title":"Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals","volume":"4","author":"Kristensen","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.xphs.2017.04.080_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bcpt.12515","article-title":"Cell-penetrating peptides as carriers for oral delivery of biopharmaceuticals","volume":"118","author":"Kristensen","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.xphs.2017.04.080_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570159X11311020006","article-title":"Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system","volume":"11","author":"Zou","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.xphs.2017.04.080_bib52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"8","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.xphs.2017.04.080_bib53","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A\u00a0truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Viv\u00e8s","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib54","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In\u00a0vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xphs.2017.04.080_bib55","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/mp100223d","article-title":"The pharmacokinetics of cell-penetrating peptides","volume":"7","author":"Sarko","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.xphs.2015.11.018","article-title":"Reversible opening of intercellular junctions of intestinal epithelial and brain endothelial cells with tight junction modulator peptides","volume":"105","author":"Bocsik","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.080_bib57","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1023\/A:1019850226631","article-title":"Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin","volume":"19","author":"Sinaga","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.147.1.195","article-title":"Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier","volume":"147","author":"Sonoda","year":"1999","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.xphs.2017.04.080_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2007.09.011","article-title":"Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A","volume":"351","author":"Song","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2008.08.047","article-title":"Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer","volume":"365","author":"Gopalakrishnan","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xphs.2017.04.080_bib62","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1096\/fj.201600827R","article-title":"Use of LDL receptor-targeting peptide vectors for in\u00a0vitro and in\u00a0vivo cargo transport across the blood-brain barrier","volume":"5","author":"Molino","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.xphs.2017.04.080_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0006-8993(87)90236-8","article-title":"Blood-brain barrier transcytosis of insulin in developing rabbits","volume":"420","author":"Duffy","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","article-title":"Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier","volume":"379","author":"Chang","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.138.4.877","article-title":"A\u00a0new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier","volume":"138","author":"Dehouck","year":"1997","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.xphs.2017.04.080_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in\u00a0vitro and rapid transcytosis through the blood-brain barrier in\u00a0vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1007592720793","article-title":"Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor","volume":"17","author":"Coloma","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bit.21764","article-title":"GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier","volume":"100","author":"Boado","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2017.04.080_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(92)91652-U","article-title":"Iron and transferrin uptake by brain and cerebrospinal-fluid in the rat","volume":"592","author":"Crowe","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib70","first-page":"1","article-title":"Optimizing transferrin-mediated transcytosis","volume":"6","author":"Lou","year":"2013","journal-title":"Sci Exch"},{"key":"10.1016\/j.xphs.2017.04.080_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tibtech.2015.10.005","article-title":"Antibody approaches to treat brain diseases","volume":"34","author":"Neves","year":"2016","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.xphs.2017.04.080_bib72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2014.10.034","article-title":"Probing the extracellular diffusion of antibodies in brain using in\u00a0vivo integrative optical imaging and ex\u00a0vivo fluorescence imaging","volume":"197","author":"Wolak","year":"2015","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.04.080_bib73","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0149-2918(02)80075-3","article-title":"Immunogenicity of therapeutic proteins: clinical implications and future prospects","volume":"24","author":"Schellekens","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib74","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1038\/srep14104","article-title":"Cargo delivery into the brain by in\u00a0vivo identified transport peptides","volume":"5","author":"Urich","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2017.04.080_bib75","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1432-1327.2001.02073.x","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib76","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1038\/srep12651","article-title":"Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2017.04.080_bib77","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.biomaterials.2012.06.063","article-title":"Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor","volume":"33","author":"Prades","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.04.080_bib78","series-title":"Patent WO2010046588: Peptide Derivatives and Use Thereof as Carriers for Molecules in the Form of Conjugates","author":"Khrestchatisky","year":"2010"},{"key":"10.1016\/j.xphs.2017.04.080_bib79","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/jm2014919","article-title":"Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting","volume":"55","author":"Malcor","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/17425240902806383","article-title":"Differential receptor-mediated drug targeting to the diseased brain","volume":"6","author":"Rip","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2017.04.080_bib81","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib82","first-page":"2799","article-title":"Increased expression of low density lipoprotein receptor-related protein\/alpha2-macroglobulin receptor in human malignant astrocytomas","volume":"57","author":"Yamamoto","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib83","first-page":"2300","article-title":"Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein","volume":"60","author":"Malet\u00ednsk\u00e1","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2017.04.080_bib84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10989-013-9378-4","article-title":"Peptide-based delivery of oligonucleotides across blood-brain barrier model","volume":"20","author":"Srimanee","year":"2014","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2016.01.014","article-title":"Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood\u2013brain barrier model","volume":"500","author":"Srimanee","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib86","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1096\/fj.11-191536","article-title":"Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides","volume":"26","author":"Ezzat","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.xphs.2017.04.080_bib87","doi-asserted-by":"crossref","first-page":"e944449","DOI":"10.4161\/21688362.2014.944449","article-title":"Pathogen-inspired drug delivery to the central nervous system","volume":"2","author":"McCall","year":"2014","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.xphs.2017.04.080_bib88","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1152\/ajpcell.00036.2011","article-title":"Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells","volume":"301","author":"Lukyanenko","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.xphs.2017.04.080_bib89","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0092-8674(92)90623-K","article-title":"Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor","volume":"69","author":"Naglich","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.xphs.2017.04.080_bib90","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1073\/pnas.79.9.2912","article-title":"Receptor-mediated endocytosis of diphtheria toxin by cells in culture","volume":"79","author":"Keen","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.080_bib91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7915.2010.00180.x","article-title":"Shiga toxin and its use in targeted cancer therapy and imaging","volume":"4","author":"Engedal","year":"2011","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.xphs.2017.04.080_bib92","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2008.09.009","article-title":"Lessons from nature: \u201cPathogen-Mimetic\u201d systems for mucosal nano-medicines","volume":"61","author":"Mrsny","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.04.080_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","article-title":"Liposome-based glioma targeted drug delivery enabled by stable peptide ligands","volume":"218","author":"Wei","year":"2015","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.04.080_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmr.300030205","article-title":"Rabies virus binding to an acetylcholine receptor alpha-subunit peptide","volume":"3","author":"Lentz","year":"1990","journal-title":"J\u00a0Mol Recognit"},{"key":"10.1016\/j.xphs.2017.04.080_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2017.04.080_bib96","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.04.080_bib97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2806-4_1","article-title":"Classes of cell-penetrating peptides","volume":"1324","author":"Pooga","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.xphs.2017.04.080_bib98","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1016\/j.biomaterials.2013.07.014","article-title":"A\u00a0pH-responsive \u03b1-helical cell penetrating peptide-mediated liposomal delivery system","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.04.080_bib99","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/mt.2011.284","article-title":"Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery","volume":"20","author":"Margus","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib100","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1039\/C4CC09441G","article-title":"Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore","volume":"51","author":"Qian","year":"2015","journal-title":"Chem Commun"},{"key":"10.1016\/j.xphs.2017.04.080_bib101","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jconrel.2012.04.003","article-title":"Cell entry of cell penetrating peptides: tales of tails wagging dogs","volume":"161","author":"Jones","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.04.080_bib102","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.xphs.2017.04.080_bib103","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/STROKEAHA.107.506048","article-title":"Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat","volume":"39","author":"Sun","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.xphs.2017.04.080_bib104","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1523\/JNEUROSCI.1207-08.2008","article-title":"Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand","volume":"28","author":"Soriano","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.xphs.2017.04.080_bib105","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.1113761109","article-title":"A\u00a0high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage","volume":"109","author":"Bach","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.080_bib106","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1523\/JNEUROSCI.22-13-05423.2002","article-title":"In\u00a0vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis","volume":"22","author":"Cao","year":"2002","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.xphs.2017.04.080_bib107","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.10356","article-title":"Intravenous TAT-Bcl-XL is protective after middle cerebral artery occlusion in mice","volume":"52","author":"Kilic","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.xphs.2017.04.080_bib108","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.0000066869.45310.50","article-title":"Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice","volume":"34","author":"Kilic","year":"2003","journal-title":"Stroke"},{"issue":"8244","key":"10.1016\/j.xphs.2017.04.080_bib109","first-page":"1","article-title":"dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis","volume":"6","author":"Lim","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2017.04.080_bib110","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/mp500113p","article-title":"Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery","volume":"11","author":"Gao","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2017.04.080_bib111","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2017.04.080_bib112","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.chembiol.2011.06.006","article-title":"Preferential uptake of L-versus D-amino acid cell-penetrating peptides in a cell type-dependent manner","volume":"18","author":"Verdurmen","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.xphs.2017.04.080_bib113","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","article-title":"A\u00a0comprehensive model for the cellular uptake of cationic cell-penetrating peptides","volume":"8","author":"Duchardt","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.xphs.2017.04.080_bib114","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/bc800194e","article-title":"Comparison of cellular uptake using 22 CPPs in 4 different cell lines","volume":"19","author":"Mueller","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib115","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.05-5523com","article-title":"Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells","volume":"20","author":"T\u00fcnnemann","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.xphs.2017.04.080_bib116","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.febslet.2007.04.046","article-title":"Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo","volume":"581","author":"B\u00e1r\u00e1ny-Wallje","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.xphs.2017.04.080_bib117","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1432-1033.2004.04022.x","article-title":"Membrane interaction and cellular internalization of penetratin peptides","volume":"271","author":"Christiaens","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.xphs.2017.04.080_bib118","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1021\/bc800212j","article-title":"Distinct uptake routes of cell-penetrating peptide conjugates","volume":"19","author":"Lundin","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2017.04.080_bib119","first-page":"1","article-title":"Cationic PTD\/CPP-mediated macromolecular delivery: charging into the cell","volume":"5247","author":"L\u00f6nn","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2017.04.080_bib120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J"},{"issue":"1661","key":"10.1016\/j.xphs.2017.04.080_bib121","first-page":"1","article-title":"Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs","volume":"3","author":"Montrose","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2017.04.080_bib122","first-page":"1","article-title":"Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis","volume":"27","author":"Bechara","year":"2013","journal-title":"Biochemistry"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:48:18Z","timestamp":1750250898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917303611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":122,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917303611"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.080","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}